PW02-040 - Low-penetrance NLRP3 variants

od Endres, T, Hofer, F, Goldbach-Mansky, R, Hoffman, HM, Blank, N, Krause, K, Rietschel, C, Horneff, G, Lohse, P, Kuemmerle-Deschner, J
Wydane 2013

PReS-FINAL-2331: Low-penetrance NLRP3 variants

od Endres, T, Hofer, F, Goldbach-Mansky, R, Hoffman, HM, Blank, N, Krause, K, Rietschel, C, Horneff, G, Lohse, P, Kuemmerle-Deschner, J
Wydane 2013

PW02-041 - Canakinumab treatment regimens in CAPS-patients

od Hofer, F, Endres, T, Kortus-Götze, B, Blank, N, Weißbarth-Riedel, E, Schuetz, C, Kallinich, T, Krause, K, Rietschel, C, Horneff, G, Kuemmerle-Deschner, J
Wydane 2013

PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients

od Hofer, F, Endres, T, Kortus-Götze, B, Blank, N, Weißbarth-Riedel, E, Schütz, C, Kallinich, T, Krause, K, Rietschel, C, Horneff, G, Kuemmerle-Deschner, J
Wydane 2013

Canakinumab treat-to target strategies increase complete response rate in CAPS

od Kuemmerle-Deschner, J, Hofer, F, Endres, T, Kortus-Goetze, B, Blank, N, Weißbarth-Riedel, E, Schuetz, C, Kallinich, T, Krause, K, Rietschel, C, Horneff, G, Benseler, SM
Wydane w Pediatr Rheumatol Online J (2015)

P01-008 – FMF genotype-phenotype correlations in Germany

od Jeske, M, Lohse, P, Kallinich, T, Berger, T, Rietschel, C, Holzinger, D, Kamlah, C, Lankisch, P, Berendes, R, Dückers, G, Horneff, G, Lilienthal, E, Haas, JP, Giese, A, Dressler, F, Berrang, J, Pütter, C, Braunewell, L, Neudorf, U, Niehues, T, Lainka, E
Wydane 2013